Extracellular NAD+ is mainly consumed through the action of CD38, a ubiquitously expressed transmembrane NAD+ glycohydrolase.23,26 CD38 expression delays cancer development by lowering NAD+ levels, with a reduction in cell metabolism that leads to cell cycle arrest.27 Extracellular NAD+ also plays important roles in immune modulation. Here, CD38 is linked to cancer.